Novonesis (Novozymes) A/S - Asset Resilience Ratio

Latest as of March 2026: 0.01%

Novonesis (Novozymes) A/S (NSIS-B) has an Asset Resilience Ratio of 0.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Dkr2.20 Million
≈ $344.19K USD Cash + Short-term Investments

Total Assets

Dkr16.52 Billion
≈ $2.59 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2002–2025)

This chart shows how Novonesis (Novozymes) A/S's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Novonesis (Novozymes) A/S to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Novonesis (Novozymes) A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Novonesis (Novozymes) A/S market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Dkr0.00 0%
Short-term Investments Dkr2.20 Million 0.01%
Total Liquid Assets Dkr2.20 Million 0.01%

Asset Resilience Insights

  • Limited Liquidity: Novonesis (Novozymes) A/S maintains only 0.01% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Novonesis (Novozymes) A/S Industry Peers by Asset Resilience Ratio

Compare Novonesis (Novozymes) A/S's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Xi'an Manareco New Materials Co.Ltd
SHG:688550
Specialty Chemicals 11.24%
EMS-CHEMIE HOLDING AG
SW:EMSN
Specialty Chemicals 28.01%
Zhejiang Satellite Petrochemical Co Ltd
SHE:002648
Specialty Chemicals 0.27%
Shanghai Putailai New Energy Technology Co.Ltd.
SHG:603659
Specialty Chemicals 9.06%
Zhejiang Longsheng Group Co Ltd
SHG:600352
Specialty Chemicals 0.80%
Jiangsu Nata Opto Electr Material
SHE:300346
Specialty Chemicals 22.39%
Lily Group Co Ltd
SHG:603823
Specialty Chemicals 0.37%
Luxi Chemical Group Co Ltd
SHE:000830
Specialty Chemicals 0.43%

Annual Asset Resilience Ratio for Novonesis (Novozymes) A/S (2002–2025)

The table below shows the annual Asset Resilience Ratio data for Novonesis (Novozymes) A/S.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.12% Dkr20.30 Million
≈ $3.18 Million
Dkr16.35 Billion
≈ $2.56 Billion
+0.10pp
2024-12-31 0.03% Dkr4.00 Million
≈ $625.83K
Dkr15.20 Billion
≈ $2.38 Billion
-0.11pp
2023-12-31 0.14% Dkr40.00 Million
≈ $6.26 Million
Dkr28.39 Billion
≈ $4.44 Billion
-0.14pp
2022-12-31 0.29% Dkr80.00 Million
≈ $12.52 Million
Dkr27.98 Billion
≈ $4.38 Billion
-0.02pp
2021-12-31 0.30% Dkr75.00 Million
≈ $11.73 Million
Dkr24.77 Billion
≈ $3.87 Billion
-0.28pp
2020-12-31 0.58% Dkr119.00 Million
≈ $18.62 Million
Dkr20.51 Billion
≈ $3.21 Billion
+0.51pp
2019-12-31 0.07% Dkr15.00 Million
≈ $2.35 Million
Dkr20.44 Billion
≈ $3.20 Billion
+0.00pp
2018-12-31 0.07% Dkr14.00 Million
≈ $2.19 Million
Dkr19.70 Billion
≈ $3.08 Billion
-0.02pp
2017-12-31 0.09% Dkr16.00 Million
≈ $2.50 Million
Dkr18.37 Billion
≈ $2.87 Billion
+0.07pp
2016-12-31 0.02% Dkr4.00 Million
≈ $625.83K
Dkr18.66 Billion
≈ $2.92 Billion
-0.09pp
2015-12-31 0.11% Dkr20.00 Million
≈ $3.13 Million
Dkr17.79 Billion
≈ $2.78 Billion
+0.02pp
2014-12-31 0.09% Dkr17.00 Million
≈ $2.66 Million
Dkr18.43 Billion
≈ $2.88 Billion
-0.43pp
2013-12-31 0.53% Dkr87.00 Million
≈ $13.61 Million
Dkr16.51 Billion
≈ $2.58 Billion
+0.23pp
2012-12-31 0.30% Dkr45.00 Million
≈ $7.04 Million
Dkr15.11 Billion
≈ $2.36 Billion
-0.05pp
2011-12-31 0.35% Dkr48.00 Million
≈ $7.51 Million
Dkr13.84 Billion
≈ $2.17 Billion
-1.07pp
2010-12-31 1.41% Dkr178.00 Million
≈ $27.85 Million
Dkr12.59 Billion
≈ $1.97 Billion
-0.81pp
2006-12-31 2.22% Dkr177.00 Million
≈ $27.69 Million
Dkr7.96 Billion
≈ $1.25 Billion
+0.16pp
2005-12-31 2.07% Dkr151.00 Million
≈ $23.63 Million
Dkr7.31 Billion
≈ $1.14 Billion
+0.76pp
2004-12-31 1.30% Dkr93.00 Million
≈ $14.55 Million
Dkr7.13 Billion
≈ $1.12 Billion
-0.20pp
2003-12-31 1.51% Dkr115.00 Million
≈ $17.99 Million
Dkr7.63 Billion
≈ $1.19 Billion
-0.48pp
2002-12-31 1.99% Dkr166.00 Million
≈ $25.97 Million
Dkr8.35 Billion
≈ $1.31 Billion
--
pp = percentage points

About Novonesis (Novozymes) A/S

CO:NSIS-B Denmark Specialty Chemicals
Market Cap
$27.41 Billion
Dkr175.18 Billion DKK
Market Cap Rank
#968 Global
#5 in Denmark
Share Price
Dkr424.70
Change (1 day)
+0.45%
52-Week Range
Dkr342.00 - Dkr442.80
All Time High
Dkr508.57
About

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The c… Read more